×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

The Diabetes and Obesity Market Opportunity

July 6, 2023

 

Health care analysts Marshall Gordon and Brittany Henderson join Jeff Schulze to highlight new treatments for the chronic conditions of diabetes and obesity. They quantify the size of the Type 1 and Type 2 diabetes and obesity markets, discuss innovations in managing diabetes and explain how GLP-1 therapeutics developed to treat diabetes can be effective in addressing the much larger obese population.

Related Perspectives

Gaining Flexibility in Shifting Growth Market
Large Cap Growth 2Q26: We believe benchmark changes, greater portfolio latitude and continued AI infrastructure leadership create a strong setup for the second half.
Participating Broadly in AI Infrastructure Buildout
International Growth ADR 2Q26: International equities rebounded sharply, with AI-linked technology companies driving outperformance for the Strategy.
Overhauling AI Exposures to Leverage Scarcity
International Growth EAFE 2Q26: We increased exposure to AI infrastructure across semiconductors, storage and networking where supply constraints and pricing power are emerging.
Midyear Outlook: What Wall of Worry?
The AOR team offers a bullish view for the second half of 2026, with a strengthening economy and robust earnings offsetting an energy shock and a hawkish Fed.
Large Cap Growth Monthly Update
Large Cap Growth May 2026: Software was a bright spot in May, with several holdings rerating on improving sentiment and solid earnings results.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

more